Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
165 studies found for:    colorectal cancer AND (women OR woman OR female)
Show Display Options
Rank Status Study
21 Active, not recruiting Screening for Gynecologic Cancers in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Patients
Condition: Colon Cancer
Intervention: Behavioral: Questionnaire
22 Recruiting Study of Vitamin D in Untreated Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: FOLFOX + bevacizumab;   Dietary Supplement: Vitamin D
23 Completed Population-Based Patient-Centric Care: Comprehensive Preventive Cancer Screening Using Health IT
Conditions: Breast Cancer;   Colorectal Cancer;   Cervical Cancer
Intervention: Other: TopCare: Use of provider knowledge vs. automated system
24 Active, not recruiting Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: bevacizumab;   Biological: cetuximab;   Drug: FOLFOX or;   Drug: FOLFIRI
25 Completed Vaccine Therapy in Treating Patients With Metastatic Cancer
Conditions: Lung Cancer;   Adult Soft Tissue Sarcoma;   Colorectal Cancer;   Bone Cancer;   Ovarian Sarcoma;   Melanoma;   Colon Cancer;   Rectal Cancer;   Breast Cancer;   Eye Cancer;   Uterine Sarcoma
Interventions: Drug: interleukin-2;   Drug: MAGE-12 peptide vaccine;   Drug: Montanide ISA-51
26 Recruiting S0820, Adenoma and Second Primary Prevention Trial
Condition: Colorectal Neoplasms
Interventions: Drug: Eflornithine placebo & sulindac placebo;   Drug: eflornithine & sulindac placebo;   Drug: Eflornithine placebo & sulindac;   Drug: Eflornithine plus sulindac
27 Completed Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
Condition: Colorectal Cancer
Interventions: Drug: tegafur-uracil;   Other: clinical observation;   Procedure: adjuvant therapy
28 Completed Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba
Condition: Colorectal Cancer
Intervention: Behavioral: Refrigerator Magnet
29 Active, not recruiting CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening
Conditions: Breast Cancer;   Cervical Cancer;   Colorectal Cancer
Interventions: Other: Clinic Intervention;   Other: Patient Intervention
30 Active, not recruiting CBPR Strategies to Increase Colorectal Cancer Screening in Ohio Appalachia
Conditions: Colon Cancer;   Rectal Cancer
Interventions: Behavioral: "Get Behind your health";   Behavioral: Peaches
31 Completed Reminding Patients of the Important of Colorectal Cancer Screening Results in Patient-Initiated Promoting Colorectal Cancer Screening Via Colonoscopy
Condition: Colon Cancer
Intervention: Other: Colorectal cancer screening pamphlet
32 Completed Information About a Doctor or a Possibility of Choosing Doctor's Gender and Attendance to Screening Colonoscopy
Conditions: Colorectal Cancer;   Screening
Intervention: Behavioral: Invitation letter
33 Completed
Has Results
Translation of Colorectal Cancer Screening Guidelines to Practice: A System Intervention
Condition: Colorectal Cancer
Intervention: Device: Electronic Consult System
34 Active, not recruiting FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer
Conditions: Colorectal Cancer;   Colorectal Carcinoma;   Liver Metastases
Interventions: Drug: Systemic chemotherapy (FOLFOX);   Device: SIR-Spheres yttrium-90 microspheres
35 Completed Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Conditions: Colorectal Neoplasms;   Digestive System Diseases;   Colonic Diseases;   Colorectal Cancer
Intervention:
36 Completed Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
Conditions: Colon Cancer;   Rectal Cancer
Interventions: Drug: celecoxib;   Other: placebo
37 Active, not recruiting Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening
Condition: Colorectal Cancer
Intervention: Behavioral: Risk Assessment
38 Recruiting Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers
Condition: Colorectal Cancer
Interventions: Other: placebo;   Drug: Acetylsalicylic acid
39 Withdrawn Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test
Condition: Colorectal Cancer
Intervention:
40 Recruiting Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Condition: Colorectal Cancer
Interventions: Biological: cetuximab;   Biological: ramucirumab;   Drug: irinotecan hydrochloride

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years